Correlation Between Barings BDC and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Barings BDC and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Barings BDC and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Barings BDC and BioNTech SE, you can compare the effects of market volatilities on Barings BDC and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Barings BDC with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Barings BDC and BioNTech.

Diversification Opportunities for Barings BDC and BioNTech

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Barings and BioNTech is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Barings BDC and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Barings BDC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Barings BDC are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Barings BDC i.e., Barings BDC and BioNTech go up and down completely randomly.

Pair Corralation between Barings BDC and BioNTech

Given the investment horizon of 90 days Barings BDC is expected to under-perform the BioNTech. But the stock apears to be less risky and, when comparing its historical volatility, Barings BDC is 3.64 times less risky than BioNTech. The stock trades about -0.17 of its potential returns per unit of risk. The BioNTech SE is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  10,187  in BioNTech SE on September 19, 2024 and sell it today you would earn a total of  1,484  from holding BioNTech SE or generate 14.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Barings BDC  vs.  BioNTech SE

 Performance 
       Timeline  
Barings BDC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Barings BDC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Barings BDC is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
BioNTech SE 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Barings BDC and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Barings BDC and BioNTech

The main advantage of trading using opposite Barings BDC and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Barings BDC position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Barings BDC and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance